Octahydroaminoacridine (succinate)
Octahydroaminoacridine succinate, a Tacrine analogue, is an acetylcholinesterse (AChE) and butyrylcholinesterase (BChE) inhibitor. Octahydroaminoacridine succinate can be used for Alzheimer's disease (AD) research[1].
Product Specifications
CAS Number
866245-79-6
UNSPSC
12352005
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/octahydroaminoacridine-succinate.html
Purity
99.88
Solubility
DMSO : 31.25 mg/mL (ultrasonic)
Smiles
O=C(O)CCC(O)=O.NC1=C(CCCC2)C2=NC3=C1CCCC3
Molecular Formula
C17H24N2O4
Molecular Weight
320.38
References & Citations
[1]Jiangbin Han, et al. Quantitation of the tacrine analogue octahydroaminoacridine in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2009 Sep 8;50 (2) :171-4.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040676-500 1x 500 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742216-500 1x 500 µL
CD50 / ICAM3 (CG106), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470461-100 1x 100 µL
Chromogranin A (PHE5), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details